| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/10/2008 | US20080086012 9-[N-phenyl-N-(9-phenylcarbazol-3-yl)amino]-10-phenylanthracene; high luminous efficiency; long lifetime |
| 04/10/2008 | US20080085904 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant |
| 04/10/2008 | US20080083606 Separation of acids from chemical reaction mixtures by means of ionic liquids |
| 04/10/2008 | CA2665398A1 Indazolyl derivatives useful as potassium channel modulating agents |
| 04/10/2008 | CA2664810A1 Substituted sulfonamide derivatives |
| 04/10/2008 | CA2664621A1 Pyrazine-2-carboxamide derivatives |
| 04/10/2008 | CA2663856A1 Jak-2 modulators and methods of use |
| 04/09/2008 | EP1907860A2 Mass labels |
| 04/09/2008 | EP1907387A1 An oxime derivative and preparations thereof |
| 04/09/2008 | EP1907385A2 Compounds |
| 04/09/2008 | EP1907379A1 Crystalline forms of (2r-trans)-6-chloro-5ýý4-ý(4-fluorophenyl)methyl¨-2,5-dimethyl-1-piperazinyl¨carbonyl¨-n,n, 1-trimethyl-alpha-oxo-1h-indole-3-acetamide monohydrochloride |
| 04/09/2008 | EP1907378A1 Preparation of terazole derivatives |
| 04/09/2008 | EP1907372A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 04/09/2008 | EP1907366A1 New imidazole derivatives, preparation method thereof and organic electronic device using the same |
| 04/09/2008 | EP1907359A2 3,5-substituted piperidine derivatives effective on renin-related disorders |
| 04/09/2008 | EP1906964A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists |
| 04/09/2008 | EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials |
| 04/09/2008 | EP0964864B1 Pyrido 2,3-d pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation |
| 04/09/2008 | CN101160305A Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics |
| 04/09/2008 | CN101160128A Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient |
| 04/09/2008 | CN101157687A 2-indole ketone compound, preparation and uses thereof |
| 04/09/2008 | CN100379733C Rriazole antifungal agent and method for preparing the same |
| 04/09/2008 | CN100379727C Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation |
| 04/09/2008 | CN100379416C Stable solid medicinal composition for oral administration. |
| 04/09/2008 | CN100379415C Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 04/08/2008 | US7355053 1-phenylpyrrolidine-2-one-3-carboxamides |
| 04/08/2008 | US7355052 Melanocortin receptors; analgesivs; antiinflammatory agents; eating disorders; psycological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents |
| 04/08/2008 | US7355045 Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof |
| 04/08/2008 | US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12 |
| 04/08/2008 | US7354938 4[2(2,4chlorophenyl)pyrazol]-phenyl-cyclopropan; 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor; antidiabrtic agent, obesity, insulin resistance; improved physicochemical (stability) and biological (activity to inhibit HSD1, specificity, bioavailability, metabolism) |
| 04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 04/08/2008 | US7354933 Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 04/08/2008 | US7354932 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/08/2008 | US7354923 Piperazine melanocortin-specific compounds |
| 04/08/2008 | CA2232663C At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
| 04/08/2008 | CA2188924C Arylpiperidine and arylpiperazine derivatives and drugs containing the same |
| 04/03/2008 | WO2008039645A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2008038018A1 Novel minor groove binders |
| 04/03/2008 | WO2008038010A1 Pyrazine derivatives and their use in therapy |
| 04/03/2008 | WO2008037789A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives |
| 04/03/2008 | WO2008037626A1 Quinoline derivatives with 5-ht-binding properties |
| 04/03/2008 | WO2008020229A3 Antibacterial pyrrolecarboxamides |
| 04/03/2008 | WO2008018639A3 Glycine transporter inhibitor |
| 04/03/2008 | WO2007145349A3 Substituted pyrrole derivatives |
| 04/03/2008 | WO2007135131A9 Substituted pyrazinone derivatives for use as a medicine |
| 04/03/2008 | WO2007130429A3 Histone deacetylase and tubulin deacetylase inhibitors |
| 04/03/2008 | WO2007015923A8 Benzimidazoles useful as inhibitors of protein kinases |
| 04/03/2008 | US20080081908 Use of metal complex compounds as oxidation catalysts |
| 04/03/2008 | US20080081902 Capping, polymerizing and separating failure sequences; kits for purifying oligonucleotides and polynucleotides |
| 04/03/2008 | US20080081832 Imidazole derivatives, processes for preparing them and their uses |
| 04/03/2008 | US20080081815 Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists |
| 04/03/2008 | US20080081811 5-[2-(cyclohexyloxy)-6-methyl-4-pyrimidinyl]-2-[5-(4-methyl-1-piperazinyl)methyl-2-pyrazinyl]amino-1,3-thiazole; anticarcinogenic agent; G1 phase in cell cycle; great selectivity |
| 04/03/2008 | US20080081810 rac-6-chloro-3-(3-chloro-benzyl)-3-(3-isopropoxy-phenylamino)-1,3-dihydro-indol-2-one; murine double minute (MDM2 ) oncogene inhibitor; feedback control loop of p53 mutant cells; inhibit the interaction between p53 and MDM2 proteins |
| 04/03/2008 | CA2664847A1 Novel minor groove binders |
| 04/03/2008 | CA2664310A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | CA2664031A1 Quinoline derivatives with 5-ht-binding properties |
| 04/02/2008 | EP1905770A1 A process for the preparation of phenyltetrazole compounds |
| 04/02/2008 | EP1905768A1 Quinoxaline derivative, and light-emitting device, electronic device using the quinoxaline derivative |
| 04/02/2008 | EP1904487A2 Indole derivatives for the treatment of tuberculosis |
| 04/02/2008 | EP1904484A1 Compounds |
| 04/02/2008 | EP1904483A1 Benzimidazole derivatives as 5-ht6,5-ht24 |
| 04/02/2008 | EP1904482A2 Indolylmaleimide derivatives |
| 04/02/2008 | EP1904479A2 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 04/02/2008 | EP1904473A1 Benzoheterocyclylethylcarboxamide derivatives |
| 04/02/2008 | EP1904457A2 Compositions and methods for inhibition of the jak pathway |
| 04/02/2008 | EP1904442A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 04/02/2008 | EP1709030B1 Indolylmaleimide derivatives |
| 04/02/2008 | EP1232147B1 Triazoles as farnesyl transferase inhibitors |
| 04/02/2008 | CN101155803A Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate |
| 04/02/2008 | CN101155802A Crystal of aminopyrrolidine derivative and prodcution method thereof |
| 04/02/2008 | CN101155801A Process for preparing 2, 3-disubstituted indoles |
| 04/02/2008 | CN101155799A Pyrimidine inhibitors of kinases |
| 04/02/2008 | CN101155797A 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
| 04/02/2008 | CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 04/02/2008 | CN101155784A Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 04/02/2008 | CN101155783A Pyrazoles |
| 04/02/2008 | CN101153458A Optical bleaching agent for phthalocyanines, preparation and application thereof |
| 04/02/2008 | CN101153038A A process for the preparation of phenyltetrazole compounds |
| 04/02/2008 | CN101153036A Organic light-emitting compound and organic light-emitting element comprising the same |
| 04/02/2008 | CN101153026A Quinoxaline derivative, and light emitting element, light emitting device, and electronic device using the quinoxaline derivative |
| 04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
| 04/02/2008 | CN100378097C Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists |
| 04/02/2008 | CN100378096C Diazepanes derivatives useful as LFA inhibitors |
| 04/02/2008 | CN100378095C Substituted indoles as alpha-1 agonists |
| 04/02/2008 | CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/02/2008 | CN100377645C Substituted arylpyrazoles as parasiticidal agents |
| 04/01/2008 | US7351841 Heterocyclic compounds and thrombopoietin receptor activators |
| 04/01/2008 | US7351838 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
| 04/01/2008 | US7351828 Benzimidazoles that are useful in treating sexual dysfunction |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351807 Cyanine-sulfenates for dual phototherapy |
| 04/01/2008 | US7351733 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 04/01/2008 | US7351730 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 04/01/2008 | US7351729 JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers |
| 04/01/2008 | US7351712 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one |
| 04/01/2008 | US7351700 4-(2-Hexylsulfanyl-6-methyl-pyrimidin-4-ylmethyl)-morpholine; antidepressant, anxiolytic agent, cognition activator; epilepsy, schizophrenia, spasticity and skeletal muscle rigidity, spinal cord injury, multiple sclerosis, amyotrophic lateral sclerosis, neuropathic pain |
| 04/01/2008 | US7351339 Using an auxiliary base to form a salt with the acid which is liquid at low enough temperature so that value product does not decompose during the removal of the liquid salt; e.g. acid catalyst removal; ionic liquids |
| 04/01/2008 | CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 03/27/2008 | WO2008035724A1 Squarylium compound, optical recording medium using the same, recording/reproduction method and optical recording apparatus |